Research Article
Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment
Figure 2
Comparison of kynurenine content of blood serum proteins in healthy controls, in RRMS patients without treatment, in RRMS patients treated with INF-beta, and in RRMS patients treated with INF-beta plus MEL.